Study identifier:D0510C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:2007-003474-26
CTIS identifier:N/A
A Phase I, Single-Centre, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 after Single Ascending Doses in Healthy Male Volunteers
Healthy
Phase 1
Yes
AZD3043
Male
53
Interventional
18 Years - 45 Years
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: AZD3043 Intravenous solution | Drug: AZD3043 intravenous solution given once as intravenous infusion over 30 minutes |